Panca Anugrah Wisesa Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Panca Anugrah Wisesa Tbk. trades at Rp9,625 (market cap 16.67T, 3.75M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Panca Anugrah Wisesa Tbk. is far larger — about 35.4× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 3.75M). Which is the better fit depends on your goals.
| MGLV | PRDL | |
|---|---|---|
Market Cap | 16.67T | 470.58B |
Volume | 3.75M | 28.43M |
Lot | 37.46K | 284.34K |
Turnover | 35.77B | 7.8B |
Average Price | 9,549.24 | 274.19 |
Value | 35.77B | 7.8B |
Indicative Equilibrium Price | 9,625 | 270 |
Indicative Equilibrium Volume | 93 | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Panca Anugrah Wisesa Tbk (the Company) formerly PT Mitra Angrah Investama was established based on Deed of Establishment of Company No. 02 dated June 06, 2012 of Chilmiyati Rufaida, S.H., Notary in Bogor.
Read more on MGLV →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →